Exact Mass: 466.1707736
Exact Mass Matches: 466.1707736
Found 150 metabolites which its exact mass value is equals to given mass value 466.1707736
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Loteprednol etabonate
Polystachin (flavone)
chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
rel-(2R,3S)-3-hydroxymethyl-9-methoxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3,6,7-tetrahydrophenanthro[4,3-b]furan-5,11-diol
6,10,15-trihydro-9(2-hydroxy-2-methylpropyl)-6,6-dimethyldibenzopyrano <2,3-c>xanthen-10-15-quinone|6,10,15-trihydro-9(2-hydroxy-2-methylpropyl)-6,6-dimethyldibenzo[a,i]pyrano [2,3-c]xanthen-10-15-quinone|Tecomaquinone III
3,3-Bis(hydroxymethyl)-4,4,8,8-tetramethoxy-2,2-binaphthalene-1,1-diol
2-Hydroxy-5-[(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy]-4,6-dimethylbenzoic acid 3-hydroxy-2,5-dimethylphenyl ester
Ala Asp Phe Asp
C20H26N4O9 (466.16997060000006)
Loteprednol etabonate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018926 - Anti-Allergic Agents
Ala Cys His His
C18H26N8O5S (466.17467860000005)
Ala Asp Asp Phe
C20H26N4O9 (466.16997060000006)
Ala Phe Asp Asp
C20H26N4O9 (466.16997060000006)
Ala His Cys His
C18H26N8O5S (466.17467860000005)
Ala His His Cys
C18H26N8O5S (466.17467860000005)
Cys Ala His His
C18H26N8O5S (466.17467860000005)
Cys Cys Lys Asn
Cys Cys Asn Lys
Cys His Ala His
C18H26N8O5S (466.17467860000005)
Cys His His Ala
C18H26N8O5S (466.17467860000005)
Cys Lys Cys Asn
Cys Lys Asn Cys
Cys Asn Cys Lys
Cys Asn Lys Cys
Asp Ala Asp Phe
C20H26N4O9 (466.16997060000006)
Asp Ala Phe Asp
C20H26N4O9 (466.16997060000006)
Asp Asp Ala Phe
C20H26N4O9 (466.16997060000006)
Asp Asp Phe Ala
C20H26N4O9 (466.16997060000006)
Asp Glu Phe Gly
C20H26N4O9 (466.16997060000006)
Asp Glu Gly Phe
C20H26N4O9 (466.16997060000006)
Asp Phe Ala Asp
C20H26N4O9 (466.16997060000006)
Asp Phe Asp Ala
C20H26N4O9 (466.16997060000006)
Asp Phe Glu Gly
C20H26N4O9 (466.16997060000006)
Asp Phe Gly Glu
C20H26N4O9 (466.16997060000006)
Asp Gly Glu Phe
C20H26N4O9 (466.16997060000006)
Asp Gly Phe Glu
C20H26N4O9 (466.16997060000006)
Asp Met Thr Thr
C17H30N4O9S (466.17334100000005)
Asp Thr Met Thr
C17H30N4O9S (466.17334100000005)
Asp Thr Thr Met
C17H30N4O9S (466.17334100000005)
Glu Asp Phe Gly
C20H26N4O9 (466.16997060000006)
Glu Asp Gly Phe
C20H26N4O9 (466.16997060000006)
Glu Phe Asp Gly
C20H26N4O9 (466.16997060000006)
Glu Phe Gly Asp
C20H26N4O9 (466.16997060000006)
Glu Gly Asp Phe
C20H26N4O9 (466.16997060000006)
Glu Gly Phe Asp
C20H26N4O9 (466.16997060000006)
Glu Met Ser Thr
C17H30N4O9S (466.17334100000005)
Glu Met Thr Ser
C17H30N4O9S (466.17334100000005)
Glu Ser Met Thr
C17H30N4O9S (466.17334100000005)
Glu Ser Thr Met
C17H30N4O9S (466.17334100000005)
Glu Thr Met Ser
C17H30N4O9S (466.17334100000005)
Glu Thr Ser Met
C17H30N4O9S (466.17334100000005)
Phe Ala Asp Asp
C20H26N4O9 (466.16997060000006)
Phe Asp Ala Asp
C20H26N4O9 (466.16997060000006)
Phe Asp Asp Ala
C20H26N4O9 (466.16997060000006)
Phe Asp Glu Gly
C20H26N4O9 (466.16997060000006)
Phe Asp Gly Glu
C20H26N4O9 (466.16997060000006)
Phe Glu Asp Gly
C20H26N4O9 (466.16997060000006)
Phe Glu Gly Asp
C20H26N4O9 (466.16997060000006)
Phe Gly Asp Glu
C20H26N4O9 (466.16997060000006)
Phe Gly Glu Asp
C20H26N4O9 (466.16997060000006)
Gly Asp Glu Phe
C20H26N4O9 (466.16997060000006)
Gly Asp Phe Glu
C20H26N4O9 (466.16997060000006)
Gly Glu Asp Phe
C20H26N4O9 (466.16997060000006)
Gly Glu Phe Asp
C20H26N4O9 (466.16997060000006)
Gly Phe Asp Glu
C20H26N4O9 (466.16997060000006)
Gly Phe Glu Asp
C20H26N4O9 (466.16997060000006)
His Ala Cys His
C18H26N8O5S (466.17467860000005)
His Ala His Cys
C18H26N8O5S (466.17467860000005)
His Cys Ala His
C18H26N8O5S (466.17467860000005)
His Cys His Ala
C18H26N8O5S (466.17467860000005)
His His Ala Cys
C18H26N8O5S (466.17467860000005)
His His Cys Ala
C18H26N8O5S (466.17467860000005)
Lys Cys Cys Asn
Lys Cys Asn Cys
Lys Asn Cys Cys
Met Asp Thr Thr
C17H30N4O9S (466.17334100000005)
Met Glu Ser Thr
C17H30N4O9S (466.17334100000005)
Met Glu Thr Ser
C17H30N4O9S (466.17334100000005)
Met Ser Glu Thr
C17H30N4O9S (466.17334100000005)
Met Ser Thr Glu
C17H30N4O9S (466.17334100000005)
Met Thr Asp Thr
C17H30N4O9S (466.17334100000005)
Met Thr Glu Ser
C17H30N4O9S (466.17334100000005)
Met Thr Ser Glu
C17H30N4O9S (466.17334100000005)
Met Thr Thr Asp
C17H30N4O9S (466.17334100000005)
Asn Cys Cys Lys
Asn Cys Lys Cys
Asn Lys Cys Cys
Ser Glu Met Thr
C17H30N4O9S (466.17334100000005)
Ser Glu Thr Met
C17H30N4O9S (466.17334100000005)
Ser Met Glu Thr
C17H30N4O9S (466.17334100000005)
Ser Met Thr Glu
C17H30N4O9S (466.17334100000005)
Ser Thr Glu Met
C17H30N4O9S (466.17334100000005)
Ser Thr Met Glu
C17H30N4O9S (466.17334100000005)
Thr Asp Met Thr
C17H30N4O9S (466.17334100000005)
Thr Asp Thr Met
C17H30N4O9S (466.17334100000005)
Thr Glu Met Ser
C17H30N4O9S (466.17334100000005)
Thr Glu Ser Met
C17H30N4O9S (466.17334100000005)
Thr Met Asp Thr
C17H30N4O9S (466.17334100000005)
Thr Met Glu Ser
C17H30N4O9S (466.17334100000005)
Thr Met Ser Glu
C17H30N4O9S (466.17334100000005)
Thr Met Thr Asp
C17H30N4O9S (466.17334100000005)
Thr Ser Glu Met
C17H30N4O9S (466.17334100000005)
Thr Ser Met Glu
C17H30N4O9S (466.17334100000005)
Thr Thr Asp Met
C17H30N4O9S (466.17334100000005)
Thr Thr Met Asp
C17H30N4O9S (466.17334100000005)
[3-[6-methoxy-1,3-dioxo-1H-benz[de]-2(3H)-isoquinolyl]-2,2-dimethylpropyl]trimethylammonium methyl sulphate
4-methylumbelliferyl phosphate, bis(2-amino-2-methyl-1,3-propanediol) salt
C18H31N2O10P (466.17162360000003)
Rogaratinib
C23H26N6O3S (466.17870060000007)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Platensimycin B2
A polycyclic cage that is platensimycin with a 1,3-oxazinane ring fused onto the aromatic ring. It is isolated from Streptomyces platensis.
[(2R,2aS,7R,7aS,7bR)-2,2a,7-trihydroxy-6,6,7b-trimethyl-1,2,4a,5,7,7a-hexahydrocyclobuta[e]inden-3-yl]methyl 3-chloro-6-hydroxy-4-methoxy-2-methylbenzoate
Phosphonooxy-[(10e)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-Tetraenyl]sulfanyl-Phosphinic Acid
6-(3-cyclopentyloxy-4-methoxyphenyl)-3-(2,5-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
C24H26N4O4S (466.16746760000007)
N-[(4-chlorophenyl)methyl]-2-[(1S,4S,6E,12R)-3,10-dioxo-2-oxa-11-azatricyclo[10.7.0.013,18]nonadeca-6,13,15,17-tetraen-4-yl]acetamide
C26H27ClN2O4 (466.16592520000006)
2,3-bis(2-furanyl)-N-[4-(4-morpholinyl)phenyl]-6-quinoxalinecarboxamide
N-[2-(2,5-dimethoxyphenyl)ethyl]-4-[(4-fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazine-6-carboxamide
N-[2-[[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]-(thiophen-2-ylmethyl)amino]-2-oxoethyl]-2-furancarboxamide
C24H26N4O4S (466.16746760000007)
[(3aS,4R,9bS)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4R,9bR)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
4-(2,8-Dimethylimidazo[1,2-a]pyridine-3-carbonyl)-1-(2-morpholin-4-ylethyl)-5-thiophen-2-ylpyrrolidine-2,3-dione
C24H26N4O4S (466.16746760000007)